Ashwat Nagarajan

1.0k total citations · 1 hit paper
4 papers, 620 citations indexed

About

Ashwat Nagarajan is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Ashwat Nagarajan has authored 4 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Oncology, 2 papers in Immunology and 1 paper in Molecular Biology. Recurrent topics in Ashwat Nagarajan's work include Pancreatic and Hepatic Oncology Research (2 papers), Acute Myeloid Leukemia Research (1 paper) and Cancer Genomics and Diagnostics (1 paper). Ashwat Nagarajan is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Acute Myeloid Leukemia Research (1 paper) and Cancer Genomics and Diagnostics (1 paper). Ashwat Nagarajan collaborates with scholars based in United States and India. Ashwat Nagarajan's co-authors include Swetha Anandhan, Jielin Liu, Shelley M. Herbrich, Sangeeta Goswami, Padmanee Sharma, Deblina Raychaudhuri, Shajedul Islam, Pratishtha Singh, James P. Allison and Gayathri Anandappa and has published in prestigious journals such as Cell, Nature Communications and Cancer Cell.

In The Last Decade

Ashwat Nagarajan

3 papers receiving 610 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immune checkpoint therapy—current perspectives and future directions

2023 579 citations Padmanee Sharma, Sangeeta Goswami et al. Cell profile →

Peers

Ashwat Nagarajan

ONCOL

IMMUN

MB

PRM

BE

Janina Dörr Germany

Shabnam Eghbali United States

Dmitrij Ostroumov Germany

Paula Dobosz Poland

Gayathri Anandappa United Kingdom

Gesa Schuebbe Germany

Luna Minute Spain

Hans Anton Schloesser Germany

Elena García-Martínez Spain

Junya Ohtake Japan

Janina Dörr Germany

Ashwat Nagarajan

253 ×0.8

ONCOL

263 ×0.8

IMMUN

177 ×1.0

MB

49 ×0.7

PRM

53 ×0.8

BE

Citations per year, relative to Ashwat Nagarajan Ashwat Nagarajan (= 1×) peers Janina Dörr

Countries citing papers authored by Ashwat Nagarajan

Since Specialization

Citations

This map shows the geographic impact of Ashwat Nagarajan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwat Nagarajan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwat Nagarajan more than expected).

Fields of papers citing papers by Ashwat Nagarajan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashwat Nagarajan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwat Nagarajan. The network helps show where Ashwat Nagarajan may publish in the future.

Co-authorship network of co-authors of Ashwat Nagarajan

This figure shows the co-authorship network connecting the top 25 collaborators of Ashwat Nagarajan. A scholar is included among the top collaborators of Ashwat Nagarajan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashwat Nagarajan. Ashwat Nagarajan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Herbrich, Shelley M., Mehdi Chaib, Swetha Anandhan, et al.. (2025). TET2-mutant clonal hematopoiesis enhances macrophage antigen presentation and improves immune checkpoint therapy in solid tumors. Cancer Cell. 44(1). 187–202.e7.

2.

Anandhan, Swetha, Shelley M. Herbrich, Sangeeta Goswami, et al.. (2024). TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer. Nature Communications. 15(1). 5291–5291. 8 indexed citations

3.

Sharma, Padmanee, Sangeeta Goswami, Deblina Raychaudhuri, et al.. (2023). Immune checkpoint therapy—current perspectives and future directions. Cell. 186(8). 1652–1669. 579 indexed citations breakdown →

4.

Ghosh, Sadashib, et al.. (2012). β-defensin-3 negatively regulates TLR4–HMGB1 axis mediated HLA-G expression in IL-1β treated glioma cells. Cellular Signalling. 25(3). 682–689. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact